Back to search

Article

Spatial remodeling of the urothelial carcinoma tumor microenvironment shapes response to neoadjuvant atezolizumab

2026-04-20

Abstract excerpt

<h4>ABSTRACT</h4> The ABACUS study was a single arm, phase II trial evaluating neoadjuvant atezolizumab in operable urothelial carcinoma. Initial bulk transcriptomic and immunohistochemistry analyses suggested links between immune activation, tissue remodeling, and resistance pathways such as transforming growth factor β that were associated with clinical outcome. To further characterize spatial and phenotypic ch...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
13a7bb90-8dfd-528a-a34d-9f21cd09a3b1
DOI
10.64898/2026.04.15.26350980
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Spatial remodeling of the urothelial carcinoma tumor microenvironment shapes response to neoadjuvant atezolizumabDOI 10.64898/2026.04.15.26350980
Select a neighboring publication to make it the new centre.